Study on Clinical and Molecular Mechanism of Adolescents Myopia Control

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100050896

Enrollment

Unknown

Registered

2021-09-07

Start date

2021-10-01

Completion date

Unknown

Last updated

2022-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Ortho-K lens group:No

Atropine group:No

Defocus lens group:No

Defocus contact lens group:No

Eligibility

Sex/Gender

All

Age

6 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Aged 6-14 years; 2. Refractive status: myopia, or myopic astigmatism; 3. Treated in our hospital and used optical or drug means to control myopia, such as orthokeratology lens, peripheral defocus lens or contact lens, and atropine.The frequency of use shall not be less than 5 days a week; 4. Han population; 5. Voluntarily participate in this research, carefully read and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Ophthalmic and systemic diseases, such as glaucoma, cataract, Marfan syndrome, spherical lens, fundus disease, eye trauma, coagulation dysfunction.

Design outcomes

Primary

Measure	Time frame
Gene sequence;	—

Countries

China

Contacts

Public ContactJiang Jun

Affiliated Ophthalmology and Optometry Hospital of Wenzhou Medical University

jjhsj@hotmail.com+86 577 88068821

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026